Syndax Pharmaceuticals (SNDX) Receivables (2024 - 2025)
Historic Receivables for Syndax Pharmaceuticals (SNDX) over the last 3 years, with Q3 2025 value amounting to $29.1 million.
- Syndax Pharmaceuticals' Receivables changed N/A to $29.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year change of. This contributed to the annual value of $11.2 million for FY2024, which is 81581.09% up from last year.
- As of Q3 2025, Syndax Pharmaceuticals' Receivables stood at $29.1 million.
- In the past 5 years, Syndax Pharmaceuticals' Receivables registered a high of $29.1 million during Q3 2025, and its lowest value of $1.2 million during Q4 2023.
- Moreover, its 3-year median value for Receivables was $19.3 million (2025), whereas its average is $16.8 million.
- Within the past 5 years, the most significant YoY rise in Syndax Pharmaceuticals' Receivables was 81581.09% (2024), while the steepest drop was 81581.09% (2024).
- Syndax Pharmaceuticals' Receivables (Quarter) stood at $1.2 million in 2023, then skyrocketed by 815.81% to $11.2 million in 2024, then soared by 158.99% to $29.1 million in 2025.
- Its Receivables was $29.1 million in Q3 2025, compared to $23.1 million in Q2 2025 and $19.3 million in Q1 2025.